PHSYX Mutual Fund

PHSYX Mutual Fund

NAV$72.89
See how much of PHSYX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
-
Expense Ratio
0.79%
Dividend Yield (Current)
0.37%
Holdings
46
Inception Date
Apr 4, 2000
Fund Family
Putnam Investments
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+3.23%
1 Year+15.17%
3 Year+8.20%
5 Year+5.28%
10 Year+9.44%

Asset Allocation

Stocks: 99.34%
Bonds: 0.33%
Cash: 0.32%
See how much of PHSYX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.13.19%
JNJJohnson & Johnson - Common9.29%
UNHUnitedhealth Group Incorporated7.29%
ABBVAbbvie Inc.6.73%
MRKMerck & Company Inc5.64%
Top 10 Concentration: 61.54%Report Date: Jul 31, 2026
Download all 46 holdings for PHSYX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.37%
Latest Distribution
$5.85
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

PHSYX Mutual Fund Overview

PHSYX Mutual Fund (Putnam Global Health Care Fund Class Y) is managed by Putnam Investments. PHSYX expense ratio is 0.79%, holding 46 positions across sectors including Health Care, Financials, Industrials. Inception date: 2000-04-04.

PHSYX performance shows a YTD return of 3.23%. The 1-year return is 15.17% and the 5-year return is 5.28%. PHSYX dividend yield stands at 0.37%.

PHSYX top holdings include Eli Lilly & Co. (13.2%), Johnson & Johnson - Common (9.3%), Unitedhealth Group Incorporated (7.3%), Abbvie Inc. (6.7%), Merck & Company Inc (5.6%). Go to all PHSYX holdings, PHSYX sectors, or PHSYX dividends.

PHSYX can be compared against other funds. Use PHSYX overlap to find shared positions, or PHSYX vs another fund for a side-by-side view. PHSYX alternatives are available via the screener, along with tax-loss harvesting opportunities.